Patents: a threat to innovation?
作者信息
Manocaran Merlina
出版信息
Science. 2010 Jan 1;327(5961):31-2; author reply 32. doi: 10.1126/science.327.5961.31.
PMID:20044557
Abstract
摘要
相似文献
1
Patents: a threat to innovation?专利：对创新的威胁？
Science. 2010 Jan 1;327(5961):31-2; author reply 32. doi: 10.1126/science.327.5961.31.
2
Intellectual property. Balancing innovation and access: patent challenges tip the scales.知识产权。平衡创新与获取：专利挑战使天平倾斜。
Science. 2009 Oct 16;326(5951):370-1. doi: 10.1126/science.1176116.
3
A generic problem.一个一般性问题。
Nat Clin Pract Gastroenterol Hepatol. 2006 Dec;3(12):649. doi: 10.1038/ncpgasthep0659.
4
Balancing innovation, access, and profits--market exclusivity for biologics.平衡创新、可及性与利润——生物制品的市场独占权
N Engl J Med. 2009 Nov 12;361(20):1917-9. doi: 10.1056/NEJMp0908496. Epub 2009 Oct 14.
5
US policy may encourage counterfeit drugs.美国政策可能会助长假药的泛滥。
Nat Biotechnol. 2003 Feb;21(2):121. doi: 10.1038/nbt0203-119.
6
Biotech patents-business as usual?生物技术专利——一切照旧？
Nat Biotechnol. 2008 Dec;26(12):1326. doi: 10.1038/nbt1208-1326.
7
Pharmaceutical patent settlements: the antitrust risks.药品专利和解：反垄断风险
Food Drug Law J. 2000;55(3):321-41.
8
A precarious balancing act--the role of the FDA as protector of public health and industry wealth.一场岌岌可危的平衡行动——美国食品药品监督管理局作为公众健康保护者和行业财富守护者的角色。
Suffolk Univ Law Rev. 2003;36(3):787-819.
9
Using market-exclusivity incentives to promote pharmaceutical innovation.利用市场独占激励措施促进药物创新。
N Engl J Med. 2010 Nov 4;363(19):1855-62. doi: 10.1056/NEJMhle1002961.
10
The ongoing regulation of generic drugs.仿制药的持续监管。
N Engl J Med. 2007 Nov 15;357(20):1993-6. doi: 10.1056/NEJMp078193.
Zotero 插件